EDIT vs. XLG

In the year-to-date period, EDIT achieves a -87.07% return, which is significantly lower than XLG's 34.91% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and Invesco S&P 500® Top 50 ETF (XLG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EDIT Sharpe Ratio is -1.15, which is lower than the XLG Sharpe Ratio of 2.42. The chart below compares the historical Sharpe Ratios of EDIT and XLG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

EDIT has not paid dividends to shareholders, while XLG's dividend yield for the trailing twelve months is around 0.53%.

The maximum EDIT drawdown since its inception was -98.55%, which is greater than XLG's maximum drawdown of -52.39%. Use the drawdown chart below to compare losses from any high point for EDIT and XLG. For additional features, visit the drawdowns tool.

Editas Medicine, Inc. (EDIT) has a higher volatility of 35.04% compared to Invesco S&P 500® Top 50 ETF (XLG) at 4.11%. This indicates that EDIT's price experiences larger fluctuations and is considered to be riskier than XLG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.